GSA Capital Partners’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-17,313
| Closed | -$411K | – | 1972 |
|
|
2021
Q4 | $411K | Sell |
17,313
-24,621
| -59% | -$608K | 0.05% | 722 |
|
|
2021
Q3 | $1.05M | Buy |
+41,934
| New | +$1.07M | 0.11% | 292 |
|
|
2021
Q2 | – | Sell |
-8,319
| Closed | -$213K | – | 1708 |
|
|
2021
Q1 | $213K | Sell |
8,319
-1,858
| -18% | -$47.6K | 0.04% | 866 |
|
|
2020
Q4 | $204K | Sell |
10,177
-6,166
| -38% | -$121K | 0.03% | 977 |
|
|
2020
Q3 | $280K | Buy |
+16,343
| New | +$309K | 0.05% | 790 |
|
|
2020
Q1 | – | Sell |
-8,900
| Closed | -$294K | – | 1708 |
|
|
2019
Q4 | $294K | Buy |
8,900
+600
| +7% | +$19.2K | 0.03% | 1043 |
|
|
2019
Q3 | $264K | Buy |
+8,300
| New | +$242K | 0.04% | 1015 |
|
|
2019
Q2 | – | Sell |
-10,876
| Closed | -$276K | – | 1834 |
|
|
2019
Q1 | $276K | Buy |
+10,876
| New | +$325K | 0.03% | 1041 |
|
|
2018
Q4 | – | Sell |
-17,323
| Closed | -$618K | – | 1868 |
|
|
2018
Q3 | $618K | Buy |
17,323
+5,768
| +50% | +$204K | 0.03% | 968 |
|
|
2018
Q2 | $399K | Buy |
+11,555
| New | +$405K | 0.02% | 1267 |
|
|
2018
Q1 | – | Sell |
-12,526
| Closed | -$478K | – | 1897 |
|
|
2017
Q4 | $478K | Sell |
12,526
-531
| -4% | -$21.2K | 0.03% | 959 |
|
|
2017
Q3 | $490K | Sell |
13,057
-8,628
| -40% | -$305K | 0.03% | 983 |
|
|
2017
Q2 | $809K | Sell |
21,685
-13,092
| -38% | -$473K | 0.05% | 714 |
|
|
2017
Q1 | $1.36M | Sell |
34,777
-23,667
| -40% | -$888K | 0.07% | 463 |
|
|
2016
Q4 | $2.03M | Buy |
58,444
+45,874
| +365% | +$1.8M | 0.12% | 198 |
|
|
2016
Q3 | $494K | Buy |
+12,570
| New | +$501K | 0.03% | 1062 |
|
|
2016
Q2 | – | Sell |
-18,934
| Closed | -$728K | – | 1971 |
|
|
2016
Q1 | $728K | Sell |
18,934
-4,540
| -19% | -$169K | 0.05% | 752 |
|
|
2015
Q4 | $1.13M | Sell |
23,474
-1,579
| -6% | -$73.1K | 0.06% | 611 |
|
|
2015
Q3 | $988K | Buy |
25,053
+14,694
| +142% | +$624K | 0.05% | 638 |
|
|
2015
Q2 | $441K | Sell |
10,359
-17,100
| -62% | -$681K | 0.02% | 1423 |
|
|
2015
Q1 | $1.08M | Sell |
27,459
-2,500
| -8% | -$92.2K | 0.04% | 802 |
|
|
2014
Q4 | $1.08M | Buy |
29,959
+9,994
| +50% | +$336K | 0.08% | 421 |
|
|
2014
Q3 | $589K | Buy |
19,965
+5,986
| +43% | +$165K | 0.03% | 824 |
|
|
2014
Q2 | $351K | Buy |
+13,979
| New | +$346K | 0.02% | 1339 |
|
Other funds holding NTUS
N
GSA Capital Partners's NTUS Position: Q1 2022 in Review
GSA Capital Partners sold out of Natus Medical Inc (NTUS) in Q1 2022, closing a stake of 17,313 shares — an estimated $411K sold.
GSA Capital Partners first reported a position in NTUS in Q2 2014 and held it in 24 quarters. The position peaked at $2.03M in Q4 2016. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.
- GSA Capital Partners reported no remaining Natus Medical Inc position as of Q1 2022 after selling out during the quarter.
- GSA Capital Partners sold 17,313 Natus Medical Inc shares in Q1 2022, an estimated $411K.
- GSA Capital Partners first reported a position in Natus Medical Inc in Q2 2014 and held it in 24 quarters.
- GSA Capital Partners's Natus Medical Inc position peaked at $2.03M in Q4 2016.
- 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.
Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.